Literature DB >> 8013405

Hypomethylation of DNA: a possible nongenotoxic mechanism underlying the role of cell proliferation in carcinogenesis.

J I Goodman1, J L Counts.   

Abstract

DNA methylation (i.e., the 5-methylcytosin content of DNA) plays a role in the regulation of gene activity. There is a persuasive body of evidence indicating that differential methylation of DNA (i.e., 5-methylcytosine versus cytosine) is a determinant of chromatin structure and that the methyl group provides a chemical signal that is recognized by trans-acting factors that regulate transcription. Hypomethylation (i.e., low levels of DNA 5-methylcytosine) of a gene is necessary but not sufficient for its expression, and, therefore, a hypomethylated gene can be considered to possess an increased potential for expression as compared to a hypermethylated gene. Cell proliferation is a fundamental component of carcinogenesis. It plays a key role in expanding clones of initiated cells and, in addition, cell replication may contribute to carcinogenesis by facilitating mutagenesis. This can occur either by causing the fixation of promutagenic DNA-damage before repair or as a consequence of a "normal" error occurring during DNA replication. During periods of cell proliferation the established pattern of DNA methylation is maintained by the action of a maintenance methylase following DNA replication. Changes in the methylation status of a gene provide a mechanism by which its potential for expression can be altered in an epigenetic heritable manner, and it is expected that modifications in DNA methylation would result from threshold-exhibiting events.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8013405      PMCID: PMC1519424          DOI: 10.1289/ehp.93101s5169

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  20 in total

1.  DNA methylation affecting the transforming activity of the human Ha-ras oncogene.

Authors:  M G Borrello; M A Pierotti; I Bongarzone; R Donghi; P Mondellini; G Della Porta
Journal:  Cancer Res       Date:  1987-01-01       Impact factor: 12.701

Review 2.  The role of DNA methylation in cancer.

Authors:  P A Jones; J D Buckley
Journal:  Adv Cancer Res       Date:  1990       Impact factor: 6.242

3.  In vitro DNA cytosine methylation of cis-regulatory elements modulates c-Ha-ras promoter activity in vivo.

Authors:  M J Rachal; H Yoo; F F Becker; J N Lapeyre
Journal:  Nucleic Acids Res       Date:  1989-07-11       Impact factor: 16.971

4.  Liver cell turnover in rats fed a choline-devoid diet.

Authors:  N Chandar; J Amenta; J C Kandala; B Lombardi
Journal:  Carcinogenesis       Date:  1987-05       Impact factor: 4.944

Review 5.  DNA methylation and epigenetic defects in carcinogenesis.

Authors:  R Holliday
Journal:  Mutat Res       Date:  1987-12       Impact factor: 2.433

6.  Chemical carcinogenesis: too many rodent carcinogens.

Authors:  B N Ames; L S Gold
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

7.  Signal transduction from membrane to cytoplasm: growth factors and membrane-bound oncogene products increase Raf-1 phosphorylation and associated protein kinase activity.

Authors:  D K Morrison; D R Kaplan; U Rapp; T M Roberts
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

8.  Altered responsiveness of rat liver epithelial cells to transforming growth factor beta 1 following their transformation with v-raf.

Authors:  A C Huggett; L L Hampton; C P Ford; P J Wirth; S S Thorgeirsson
Journal:  Cancer Res       Date:  1990-12-01       Impact factor: 12.701

9.  Altered methylation of ras oncogenes in benzidine-induced B6C3F1 mouse liver tumors.

Authors:  R L Vorce; J I Goodman
Journal:  Toxicol Appl Pharmacol       Date:  1989-09-15       Impact factor: 4.219

10.  Expression of the c-raf protooncogene, gamma-glutamyltranspeptidase, and gap junction protein in rat liver neoplasms.

Authors:  D G Beer; M J Neveu; D L Paul; U R Rapp; H C Pitot
Journal:  Cancer Res       Date:  1988-03-15       Impact factor: 12.701

View more
  11 in total

Review 1.  DNA hypomethylation in the origin and pathogenesis of human diseases.

Authors:  Igor P Pogribny; Frederick A Beland
Journal:  Cell Mol Life Sci       Date:  2009-03-27       Impact factor: 9.261

Review 2.  Epigenetic changes in the myelodysplastic syndrome.

Authors:  Jean-Pierre Issa
Journal:  Hematol Oncol Clin North Am       Date:  2010-04       Impact factor: 3.722

3.  DNA Methylation and Flavonoids in Genitourinary Cancers.

Authors:  Neelam Mukherjee; Addanki P Kumar; Rita Ghosh
Journal:  Curr Pharmacol Rep       Date:  2015-04-01

Review 4.  Circadian rhythm disruption in cancer biology.

Authors:  Christos Savvidis; Michael Koutsilieris
Journal:  Mol Med       Date:  2012-12-06       Impact factor: 6.354

5.  Promoter hypomethylation as potential confounder of Ras gene overexpression and their clinical significance in subsets of urothelial carcinoma of bladder.

Authors:  Kiran Tripathi; Apul Goel; Atin Singhai; Minal Garg
Journal:  Mol Biol Rep       Date:  2021-02-23       Impact factor: 2.316

6.  Biological Basis of Differential Susceptibility to Hepatocarcinogenesis among Mouse Strains.

Authors:  Robert R Maronpot
Journal:  J Toxicol Pathol       Date:  2009-04-06       Impact factor: 1.628

7.  DNA methylation in multiple myeloma is weakly associated with gene transcription.

Authors:  Sungwon Jung; Seungchan Kim; Molly Gale; Irene Cherni; Rafael Fonseca; John Carpten; Bodour Salhia
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

Review 8.  Anomalous nonidentity between Salmonella genotoxicants and rodent carcinogens: nongenotoxic carcinogens and genotoxic noncarcinogens.

Authors:  K Yoshikawa
Journal:  Environ Health Perspect       Date:  1996-01       Impact factor: 9.031

Review 9.  Cell proliferation and chemical carcinogenesis: symposium overview.

Authors:  R L Melnick; J Huff; J C Barrett; R R Maronpot; G Lucier; C J Portier
Journal:  Environ Health Perspect       Date:  1993-12       Impact factor: 9.031

10.  Colorectal tumor molecular phenotype and miRNA: expression profiles and prognosis.

Authors:  Martha L Slattery; Jennifer S Herrick; Lila E Mullany; Erica Wolff; Michael D Hoffman; Daniel F Pellatt; John R Stevens; Roger K Wolff
Journal:  Mod Pathol       Date:  2016-05-20       Impact factor: 7.842

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.